Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms BC2P |
Target |
Action degraders |
Mechanism BTK degraders(Tyrosine-protein kinase BTK degraders) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC56H67F2N9O9 |
InChIKeyUGRJNHBWVKZNEV-YMMKHCTOSA-N |
CAS Registry- |